RxSight (RXST) Total Liabilities (2020 - 2026)

RxSight (RXST) has 7 years of Total Liabilities data on file, last reported at $36.7 million in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities rose 8.81% year-over-year to $36.7 million; the trailing twelve-month figure through Mar 2026 stood at $36.7 million (up 8.81% YoY), and the FY2025 full-year result was $36.1 million, down 3.2% from the prior year.
• Total Liabilities for Q1 2026 stood at $36.7 million, up from $36.1 million in the prior quarter.
• Across five years, Total Liabilities topped out at $60.3 million in Q4 2022 and bottomed at $19.2 million in Q1 2024.
• The 5-year median for Total Liabilities is $36.1 million (2025), against an average of $38.8 million.
• The widest annual swing landed in 2022, when Total Liabilities plunged 82.15%; it then surged 75.34% in 2025.
• A 5-year view of Total Liabilities shows it stood at $60.3 million in 2022, then sank by 63.18% to $22.2 million in 2023, then surged by 68.22% to $37.3 million in 2024, then retreated by 3.2% to $36.1 million in 2025, then advanced by 1.57% to $36.7 million in 2026.
• The last three Total Liabilities figures came in at $36.7 million (Q1 2026), $36.1 million (Q4 2025), and $32.6 million (Q3 2025), per Business Quant data.

Peer Comparison